Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus

OBJECTIVE: To investigate the long‐term safety and efficacy of intravenous (IV) belimumab plus standard of care (SOC) therapy for systemic lupus erythematosus (SLE) in patients with active, autoantibody‐positive SLE. METHODS: The study was designed as a multicenter, open‐label, continuation study of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Arthritis Rheumatol
Main Authors: Wallace, Daniel J., Ginzler, Ellen M., Merrill, Joan T., Furie, Richard A., Stohl, William, Chatham, W. Winn, Weinstein, Arthur, McKay, James D., McCune, W. Joseph, Petri, Michelle, Fettiplace, James, Roth, David A., Ji, Beulah, Heath, Amy
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Systemic Lupus Erythematosus
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6617785/
https://ncbi.nlm.nih.gov/pubmed/30771238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40861
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares